Home › Rating Schedule › Eye
Diagnostic Code 6014: Malignant neoplasms of the eye, orbit, and adnexa (excluding skin)
Eye · 38 CFR §4.79 · All codes in this system
| Evaluation criteria | Rating |
|---|---|
| Malignant neoplasms of the eye, orbit, and adnexa (excluding skin) that require therapy that is comparable to those used for systemic malignancies, i.e., systemic chemotherapy, X-ray therapy more extensive than to the area of the eye, or surgery more extensive than enucleation | 100% |
| Note: Continue the 100 percent rating beyond the cessation of any surgical, X-ray, antineoplastic chemotherapy, or other therapeutic procedure. Six months after discontinuance of such treatment, the appropriate disability rating will be determined by mandatory VA examination. Any change in evaluation based upon that or any subsequent examination will be subject to the provisions of ยง 3.105(e) of this chapter. If there has been no local recurrence or metastasis, evaluate based on residuals | |
| Malignant neoplasms of the eye, orbit, and adnexa (excluding skin) that do not require therapy comparable to that for systemic malignancies: | |
| Separately evaluate visual and nonvisual impairment, e.g., disfigurement (diagnostic code 7800), and combine the evaluations | |
Use this rating
Open the combined ratings calculator with this percentage already entered, then add your other rated conditions:
Source: eCFR Title 38, 38 CFR §4.79, current as of 2026-11-05. Criteria text is the regulatory text, reproduced verbatim for reference; it is not legal advice.